Ignite Creation Date:
2024-05-05 @ 11:24 AM
Last Modification Date:
2024-10-26 @ 9:06 AM
Study NCT ID:
NCT00022659
Status:
COMPLETED
Last Update Posted:
2019-07-24
First Post:
2001-08-10
Brief Title:
Bevacizumab in Treating Patients With Persistent or Recurrent Ovarian Epithelial Cancer or Primary Peritoneal Cancer
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Primary Peritoneal Cavity Cancer |
| Recurrent Ovarian Epithelial Cancer |
| Stage IV Ovarian Epithelial Cancer |
Keywords: